Jin Young Lee,Dae Bong Kim,Beom Seok Kwak et al.
Jin Young Lee et al.
A primary fibrosarcoma of the breast is a rare tumor. Here we report on a case of a primary fibrosarcoma of the breast that presented as a palpable left breast mass in a 47-year-old woman. The physical examination revealed a 3 cm sized, rou...
Youn Jeong Kim,Ju Won Lee,Suk Jin Choi et al.
Youn Jeong Kim et al.
Hidradenoma papilliferum (HP) is a benign neoplasm arising from mammary-like glands which typically involves the dermal layer of the female anogenital area. The prognosis for HP is good. Recurrence is unusual and is typically attributed to ...
Feasibility of sentinel lymph node biopsy in breast cancer patients with initial axillary lymph node metastasis after primary systemic therapy [0.03%]
新辅助治疗后腋窝已有转移的乳腺癌患者行前哨淋巴结活检的可行性研究
Eunyoung Kang,Il Yong Chung,Sang-Ah Han et al.
Eunyoung Kang et al.
Purpose: Primary systemic therapy (PST) downstages up to 40% of initial documented axillary lymph node (ALN) metastases in breast cancer. The current surgical treatment after PST consists of breast tumor resection and axi...
Phase II Study of Vinorelbine Plus Trastuzumab in HER2 Overexpressing Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes [0.03%]
表阿霉素和紫杉醇治疗的、HER2过度表达的转移性乳腺癌患者中 vinorelbine联合曲妥珠单抗Ⅱ期临床研究
Yu Rim Lee,Seok Jae Huh,Dong Hyun Lee et al.
Yu Rim Lee et al.
Purpose: The role of first-line trastuzumab-based therapy has been firmly established in patients with human epidermal growth factor receptor-2 (HER2) positive metastatic breast cancer. In this trial, we evaluated the eff...
Efficacy of fulvestrant in heavily pretreated postmenopausal women with advanced breast cancer: a preliminary report [0.03%]
氟维司群治疗多次经治的绝经后晚期乳腺癌患者疗效的初步分析报告
Changhoon Yoo,Sung-Bae Kim,Jin-Hee Ahn et al.
Changhoon Yoo et al.
Purpose: Fulvestrant, a potent estrogen receptor (ER) antagonist with a novel mechanism of action, has shown efficacy in pretreated patients with advanced breast cancer. We assessed the efficacy and tolerability of fulves...
Comparison of Doxorubicin plus docetaxel neoadjuvant chemotherapy with Doxorubicin plus vinorelbine in primary breast cancer [0.03%]
多柔比星联合多西他赛与多柔比星联合长春瑞滨新辅助化疗治疗原发性乳腺癌的对比研究
Geumhee Gwak,Ji-Young Kim,Keongmee Park et al.
Geumhee Gwak et al.
Purpose: This study was performed to compare the therapeutic efficacy and toxicity of doxorubicin plus docetaxel neoadjuvant chemotherapy (NC) with doxorubicin plus vinorelbine NC. ...
Tumor characteristics influencing non-sentinel lymph node involvement in clinically node negative patients with breast cancer [0.03%]
影响临床分期腋窝阴性乳腺癌患者非哨点淋巴结转移的肿瘤特征分析
Gunay Gurleyik,Fugen Aker,Ali Aktekin et al.
Gunay Gurleyik et al.
Purpose: The negative sentinel lymph node (SLN) biopsy avoids conventional axillary dissection in patients with breast cancer with clinically negative axilla. Despite negative SLN, there is a risk of leaving involved non-...
Ultrasound and clinicopathological characteristics of triple receptor-negative breast cancers [0.03%]
三阴性乳腺癌的超声及临床病理特征分析
Yoon Jung Choi,Min Hyun Seong,Seon Hyeong Choi et al.
Yoon Jung Choi et al.
Purpose: Triple receptor-negative (TRN) breast cancer is associated with high risk of recurrence and poor prognosis. The present study assessed the clinicopathologic characteristics and ultrasound (US) features of TRN bre...
Quality of Life Differences between Younger and Older Breast Cancer Patients [0.03%]
年轻和老年乳腺癌患者生活质量的差异
Byeong-Woo Park,Suyun Lee,Ah Reum Lee et al.
Byeong-Woo Park et al.
Purpose: This study was designed to investigate quality of life (QOL) differences between younger (
D2-40, Podoplanin, and CD31 as a Prognostic Predictor in Invasive Ductal Carcinomas of the Breast [0.03%]
乳腺浸润性导管癌的预后标志物D2-40、podoplanin和CD31
Jung Ah Lee,Jeoung Won Bae,Sang Uk Woo et al.
Jung Ah Lee et al.
Purpose: Distant metastasis and recurrence are major prognostic factors associated with breast cancer. Both lymphovascular invasion (LVI) and blood vessel invasion (BVI) are important routes for metastasis to regional lym...